Clinical Benefit
| Moderate |
Le service médical rendu par cette spécialité est modéré dans l’hypertrophie bénigne de la prostate non compliquée.
|
Clinical Added Value
| no clinical added value |
OMEXEL LP 0,4mg (gel matriciel) n’apporte pas d’amélioration du service.
|
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
rngnaa9AwpQA21Rh